Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

IEX Schedule One Update

6 Jun 2007 17:27

First Derivatives PLC06 June 2007 IEX SCHEDULE ONE-PRE-ADMISSION ANNOUNCEMENT COMPANY NAME: First Derivatives public limited companyCOUNTRY OF INCORPORATION: Northern IrelandCOMPANY ADDRESS: Registered Office: 40 Church Street, Belfast, Co Antrim, BT1 4FRCOMPANY BUSINESS OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTMENT STRATEGY TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE TWO, PARAGRAPH (J) OF THE IEX RULES: First Derivatives plc provides a range of services and software to the capital markets industry. Our customers includeinvestment banks, hedge funds, Specialised Investment Vehicles and Derivatives Product Companies as well as softwarecompanies selling to these organisations. Our range of services include project management and integration services,outsourced systems development and support, training and the provision of niche trading and risk managementapplications.DETAILS OF SECURITIES TO BE ADMITTED (i.e. where known, number of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares): 12,994,158 Ordinary shares of 0.5 pence eachCAPITAL TO BE RAISED ON ADMISSION: None FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS: Robert David Anderson - Non-executive chairman Brian Gerard Conlon - Managing director Michael George O'Neill - Operations Director Adrian John Toner - Non-executive DirectorPERSON(S) INTERESTED IN 5% OR MORE OF THE ISSUER CAPITAL, EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL BEFORE AND AFTER ADMISSION: Brian Gerard Conlon - 70.1% Michael George O'Neill 8.0%NAMES AND ADDRESSES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE TWO, PARAGRAPH (H) OF THE IEX RULES: NoneANTICIPATED ACCOUNTING REFERENCE DATE: 28 FebruaryEXPECTED ADMISSION DATE: 8 June 2007NAME AND ADDRESS OF IEX ADVISER: Goodbody Corporate Finance, Ballsbridge Park, Ballsbridge, Dublin 4NAME AND ADDRESS OF BROKER:Goodbody Stockbrokers, Ballsbridge Park, Ballsbridge, Dublin 4 DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIESN/ADATE OF NOTIFICATION: 10 May 2007QUOTED APPLICANTS MUST ALSO COMPLETE THE FOLLOWING: THE NAME OF THE IEX DESIGNATED MARKET UPON WHICH THE APPLICANT SECURITIES HAVE BEEN TRADED: AIM market of the London Stock Exchange THE DATE FROM WHICH THE APPLICANT SECURITIES HAVE BEEN SO TRADED: 28 March 2002CONFIRMATION THAT, FOLLOWING DUE AND CAREFUL ENQUIRY, THE APPLICANT HAS ADHERED TO ANY LEGAL AND REGULATORYREQUIREMENTS INVOLVED IN HAVING ITS SECURITIES TRADED UPON SUCH A MARKET: First Derivatives confirms, having made due and careful enquiry, that as at the date of this announcement the Companyhas adhered to the legal and regulatory requirements involved in having its securities traded on the AIM market of theLondon Stock Exchange. AN ADDRESS OR WEB-SITE ADDRESS WHERE ANY DOCUMENTS OR ANNOUNCEMENTS WHICH THE APPLICANT HAS MADE PUBLIC OVER THE LAST TWO YEARS (IN CONSEQUENCE OF HAVING ITS SECURITIES SO TRADED) ARE AVAILABLE: www.firstderivatives.comDETAILS OF THE APPLICANT STRATEGY FOLLOWING ADMISSION INCLUDING, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTMENT STRATEGYFirst Derivatives plc will continue to pursue its current strategy of maximising shareholder value by growing itsbusiness within each of its 3 main profit centres. Personnel can transfer seamlessly between these centres andopportunities exist for cross-selling services and software. Capital Markets First Derivatives will continue to expand relationships with existing customers and to seek new customers for itsgeneral consulting services. The company has a strong brand and a critical mass of consultants which will allow it tofocus on providing teams of highly skilled consultants on long-term projects or projects with a significant potentialfor recurring revenue. Sales Partnerships First Derivatives operates partnerships with a number of non-competing software vendors, including one with KX Systems(www.kx.com). New opportunities will be sought to expand the portfolio of partners and to increase revenue fromexisting partnerships. These partnerships allow more points of entry for establishing direct relationships withinvestment banking customers. Product Development A number of R&D initiatives are on the verge of commercial exploitation. These are in areas such as algorithmic programtrading, compliance and market data management. A DESCRIPTION OF ANY SIGNIFICANT CHANGE IN FINANCIAL OR TRADING POSITION OF THE APPLICANT, WHICH HAS OCCURRED SINCE THE END OF THE LAST FINANCIAL PERIOD FOR WHICH AUDITED STATEMENTS HAVE BEEN PUBLISHED: Otherwise than disclosed in the Company public records, there has been no significant change in the financial ortrading position of the Company since 28 February 2007, the end of the last financial year for which audited financialstatements have been published. A STATEMENT THAT THE DIRECTORS OF THE APPLICANT HAVE NO REASON TO BELIEVE THAT THE WORKING CAPITAL AVAILABLE TO IT OR ITS GROUP WILL BE INSUFFICIENT FOR AT LEAST TWELVE MONTHS FROM THE DATE OF ITS ADMISSION: The directors of the Company have no reason to believe that the working capital available to it or its group will be insufficient for at least twelve months from the date of its admission. DETAILS OF ANY LOCK-IN ARRANGEMENTS PURSUANT TO RULE 7 OF THE IEX RULES: NoneA BRIEF DESCRIPTION OF THE ARRANGEMENTS FOR SETTLING THE APPLICANT SECURITIES: Following Admission settlement of transactions in the Ordinary Shares may take place within the CREST system ifShareholders so wish. CREST is a voluntary system and holders of Ordinary Shares who wish to receive and retain sharecertificates will be able to do. A WEBSITE ADDRESS DETAILING THE RIGHTS ATTACHING TO THE APPLICANT SECURITIES: Details are contained in the Admission Document available at www.firstderivatives.com INFORMATION EQUIVALENT TO THAT REQUIRED FOR AN ADMISSION DOCUMENT WHICH IS NOT CURRENTLY PUBLIC: Not applicable A WEBSITE ADDRESS OF A PAGE CONTAINING THE APPLICANT LATEST ANNUAL REPORT AND ACCOUNTS WHICH MUST HAVE A FINANCIAL YEAR END NOT MORE THAN NINE MONTHS PRIOR TO ADMISSION AND FULLY AUDITED INTERIM RESULTS WHERE APPLICABLE. THE ACCOUNTS MUST BE PREPARED ACCORDING TO IRISH, UK OR US GAAP OR INTERNATIONAL ACCOUNTING STANDARDS. www.firstderivatives.comTHE NUMBER OF EACH CLASS OF SECURITIES HELD IN TREASURY. None This announcement has been issued through the Companies Announcement Service of The Irish Stock Exchange. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th Oct 20207:00 amRNSNotice of Results
30th Sep 20204:27 pmRNSTotal Voting Rights
16th Sep 20207:00 amRNSDirectorate Change
2nd Sep 20203:54 pmRNSIssue of Equity
2nd Sep 20207:00 amRNSTotal Voting Rights
26th Aug 20208:46 amRNSIssue of Equity
20th Aug 20206:10 pmRNSHolding(s) in Company
6th Aug 20207:00 amRNSEuronext Growth Dublin Notice
31st Jul 202012:01 pmRNSIssue of Equity and Total Voting Rights
20th Jul 20207:00 amRNSAppointment of Kx Chief Revenue Officer
14th Jul 20207:00 amRNSDirectorate Change
9th Jul 20207:00 amRNSShare Option Plan Awards
9th Jul 20207:00 amRNSEuronext Growth Dublin Notice
8th Jul 20204:07 pmRNSResult of AGM
8th Jul 20207:00 amRNSAGM Statement
7th Jul 202012:02 pmRNSPrice Monitoring Extension
6th Jul 20207:00 amRNSSenior Executive Appointment
3rd Jul 202010:23 amRNSIssue of Equity
2nd Jul 20207:00 amRNSDirectorate Change
30th Jun 20202:35 pmRNSTotal Voting Rights
9th Jun 20208:00 amRNSEuronext Growth Dublin Notice
8th Jun 20204:30 pmRNSNotice of AGM
3rd Jun 20202:33 pmRNSIssue of Equity
1st Jun 202011:00 amRNSTotal Voting Rights
28th May 20207:00 amRNSEuronext Growth Dublin Notice
22nd May 20205:59 pmRNSIssue of Equity - Correction
21st May 20204:19 pmRNSIssue of Equity
19th May 20207:00 amRNSGlobal partnership agreement
19th May 20207:00 amRNSFull year results for the year ended 29 Feb 2020
9th Apr 20207:00 amRNSTrading Statement
31st Mar 202010:06 amRNSTotal Voting Rights
12th Mar 20207:00 amRNSEuronext Growth Dublin Notice
6th Mar 202010:52 amRNSIssue of Equity
17th Feb 20207:00 amRNSMajor oilfield services contract win
31st Jan 202012:01 pmRNSTotal Voting Rights
30th Jan 20207:00 amRNSEuronext Growth Dublin Notice
24th Jan 20202:01 pmRNSIssue of Equity
15th Jan 20207:00 amRNSCEO appointment and Board changes
31st Dec 20199:58 amRNSTotal Voting Rights
17th Dec 20197:00 amRNSEuronext Growth Dublin Notice
12th Dec 20197:00 amRNSEuronext Growth Dublin Notice
11th Dec 20193:10 pmRNSIssue of Equity
11th Dec 20197:50 amRNSHolding(s) in Company
6th Dec 20193:10 pmRNSIssue of Equity
29th Nov 20194:46 pmRNSTotal Voting Rights
15th Nov 20197:00 amRNSEuronext Growth Dublin Notice
8th Nov 20192:32 pmRNSIssue of Equity
5th Nov 20197:00 amRNSInterim results for the six months ended 31.08.19
1st Nov 201910:15 amRNSHolding(s) in Company
8th Oct 20197:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.